Drug Shortage Report for FASTURTEC
| Report ID | 153375 |
| Drug Identification Number | 02248416 |
| Brand name | FASTURTEC |
| Common or Proper name | Fasturtec |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RASBURICASE |
| Strength(s) | 1.5MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 3 |
| ATC code | V03AF |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-01-17 |
| Actual start date | |
| Estimated end date | 2022-02-04 |
| Actual end date | 2022-01-25 |
| Shortage status | Resolved |
| Updated date | 2022-02-10 |
| Company comments | The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-02-10 | French | Compare |
| v3 | 2022-02-10 | English | Compare |
| v2 | 2022-01-21 | French | Compare |
| v1 | 2022-01-21 | English | Compare |
Showing 1 to 4 of 4